Cord Blood News — Insception Lifebank

Cord Blood News

Cord Blood News

Cell Care group of cord blood banks announces strategic investment in ExCellThera

November 15, 2018

TORONTO/MELBOURNE, August 1st, 2018 The Cell Care international cord blood banking group (“Cell Care”) – comprising Insception Lifebank and Cells for Life in Canada – today announced a strategic investment in ExCellThera Inc., a leading Montreal-based biotechnology company delivering molecules and bioengineering solutions to expand blood stem cells for therapeutic use. The investment and associated

Read More

Grand River Hospital increases cord blood educational resources for new moms

March 5, 2018

Grand River Hospital increases cord blood educational resources for new moms A new partnership announced between Grand River Hospital (GRH) and Insception Lifebank cord blood bank will provide additional educational resources to pregnant moms in Waterloo Region. GRH will feature Insception Lifebank’s educational information on the hospital’s website as well as in patient care areas within

Read More

Insception Biosciences Inc. joins with Cell Care to Establish Global Platform

October 5, 2016

Insception Biosciences Inc. joins with Cell Care to Establish Global Platform Insception Lifebank, Canada’s largest private cord blood & tissue bank has today announced it has joined with Cell Care, Australia’s largest cord blood bank. The combined entity creates one of the world’s top 10 companies in the sector. Together, they store over 100,000 client

Read More

Insception Lifebank collaborates with leading institutions to develop iPSCs from cord blood and cord tissue

June 28, 2016

Joint venture between Insception Lifebank, the Lunenfeld-Tanenbaum Research Institute and Ontario Centres of Excellence aims to  develop iPSCs from cord blood and cord tissue. Insception Lifebank Cord Blood Program (“Insception”) is excited to announce its collaboration with Dr. Ian Rogers, from the The Lunenfeld-Tanenbaum Research Institute, part of Sinai Health System, to develop clinical grade

Read More

Insception Lifebank Releases More Cord Blood Units for Regenerative Medicine

May 4, 2016

In April 2016, Insception Lifebank released two more cord blood units (CBUs) for clinical trials in regenerative medicine.  Both CBUs were shipped to Duke University Medical Center in Durham, North Carolina and used in two different clinical trials for Cerebral Palsy (CP). On April 12, the first child, born in Prince George, BC, was infused

Read More

Canadian Clinical Trial for Cancer Patients using Stem Cells

December 21, 2015

Health Canada has approved the initiation of a Phase I/II clinical trial for ExCellThera’s lead product, ECT-100, for the expansion of hematopoietic stem cells (HSCs). The trial will begin early 2016 and will enroll up to 25 patients who require stem cell transplantation for the treatment of acute myeloid leukemia (AML) and other malignant blood disorders with no

Read More

Canada at the Forefront Emerging Cell Therapy

October 30, 2015

Nolan Laberge had acute myeloid leukemia, an aggressive type of blood cancer. After several rounds of chemotherapy, Nolan received a stem cell transplant in May 2012. Nolan was deemed cured almost immediately after the transplant.

Read More

Umbilical cord blood transplant saved a boy’s life

September 15, 2015

Nolan Laberge had acute myeloid leukemia, an aggressive type of blood cancer. After several rounds of chemotherapy, Nolan received a stem cell transplant in May 2012. Nolan was deemed cured almost immediately after the transplant.

Read More

$114 Million for Revolutionary Regenerative Medicine Progam

July 29, 2015

Thanks to the federal government’s $114-million grant, Toronto has been firmly established as the leader of the pack when it comes to centers for the design and manufacture of cells, tissues and organs used to treat degenerative disease.

Read More